Concepts (53)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Esophageal Neoplasms | 1 | 2005 | 86 | 0.210 |
Why?
|
| Thoracic Wall | 1 | 2023 | 20 | 0.210 |
Why?
|
| Salmonella Infections | 1 | 2023 | 42 | 0.210 |
Why?
|
| Salmonella enterica | 1 | 2023 | 26 | 0.200 |
Why?
|
| Haemophilus Infections | 1 | 2023 | 13 | 0.200 |
Why?
|
| Mycoplasma | 1 | 2023 | 8 | 0.200 |
Why?
|
| Bronchiolitis | 1 | 2023 | 17 | 0.200 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 71 | 0.200 |
Why?
|
| Bacteremia | 1 | 2023 | 94 | 0.190 |
Why?
|
| Sarcoma | 1 | 2017 | 36 | 0.130 |
Why?
|
| Lecithin Cholesterol Acyltransferase Deficiency | 1 | 2011 | 2 | 0.090 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2011 | 6 | 0.090 |
Why?
|
| Homozygote | 1 | 2011 | 124 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2011 | 185 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 686 | 0.080 |
Why?
|
| Epoprostenol | 1 | 2010 | 15 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 68 | 0.080 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2010 | 61 | 0.080 |
Why?
|
| Biopsy | 1 | 2010 | 446 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 2010 | 297 | 0.070 |
Why?
|
| Lung | 1 | 2010 | 955 | 0.060 |
Why?
|
| Neoadjuvant Therapy | 1 | 2005 | 88 | 0.050 |
Why?
|
| Sulfamethoxazole | 1 | 2023 | 5 | 0.050 |
Why?
|
| Trimethoprim | 1 | 2023 | 7 | 0.050 |
Why?
|
| Serogroup | 1 | 2023 | 35 | 0.050 |
Why?
|
| Salmonella | 1 | 2023 | 44 | 0.050 |
Why?
|
| Abscess | 1 | 2023 | 80 | 0.050 |
Why?
|
| Survival Rate | 1 | 2005 | 854 | 0.050 |
Why?
|
| Humans | 6 | 2023 | 63587 | 0.040 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2017 | 8 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 46 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2017 | 41 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2017 | 167 | 0.030 |
Why?
|
| Corneal Opacity | 1 | 2011 | 4 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 39 | 0.020 |
Why?
|
| Apolipoprotein A-I | 1 | 2011 | 23 | 0.020 |
Why?
|
| Proteinuria | 1 | 2011 | 43 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 36 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 204 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2010 | 18 | 0.020 |
Why?
|
| Pulmonary Circulation | 1 | 2010 | 27 | 0.020 |
Why?
|
| Cholesterol | 1 | 2011 | 259 | 0.020 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2010 | 43 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 417 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2010 | 173 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 158 | 0.020 |
Why?
|
| Female | 2 | 2023 | 32979 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2010 | 140 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 1591 | 0.020 |
Why?
|
| Aged | 1 | 2023 | 14481 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 5483 | 0.020 |
Why?
|
| Middle Aged | 2 | 2011 | 17682 | 0.010 |
Why?
|
| Male | 2 | 2011 | 29967 | 0.010 |
Why?
|